It’s Wednesday. With the release of Google’s Bard chatbot, we’ve got large language models on our minds. Can they help us survive the onslaught of group chat texts we’ll get when Succession returns this weekend?
Until then, we invite you to take our latest reader survey—you’re brilliant, you know that, right? We sure do. That’s why we need your help to make our coverage better. If you can spare a couple of minutes to tell us how we’re doing, you’ll be in the running for a $250 AmEx gift card. Take our survey here.
In today’s edition:
—Hayden Field, Maeve Allsup
|
|
Ram Trucks
Battery tech may be one of the hottest automotive investments this winter—at least according to VC dollars.
Venture capitalists invested more than $647 million in automotive industry startups in February, and more than 70% of that funding went to battery tech companies, Automotive News reported.
Fully charged
The biggest bet in that sector was Our Next Energy, a Michigan-based energy storage company that netted a $300 million Series B at a post-money valuation of $1.2 billion.
The funding round came alongside an additional $220 million in grants from the State of Michigan. One of the company’s goals is to produce enough LFP batteries to power 200,000 electric vehicles by 2027, the FT reported.
Why it matters: LFP batteries are widely seen as a smart way to power EVs since they’re less expensive to manufacture than some methods and provide faster vehicle charging.
But the tech is a relatively new manufacturing bet for the US. In 2022, LFPs represented about half the battery capacity of EVs sold in China, compared to only 9% for the US—and that’s up from zero for the US in 2021, according to research from Adamas Intelligence cited by the FT. When Our Next Energy completes its factory, chances are that number will grow even larger.—HF
|
|
You know Johnson & Johnson® as the company behind Tylenol®, Listerine®, and even everyone’s trusty friend, BAND-AID®. Now they’re funding one more solution that could treat millions—and you can invest alongside them.
Cytonics aims to have the first and only treatment that can reverse osteoarthritis (OA). Over 600m people worldwide suffer from this joint-degrading disease, and there is currently no treatment that targets its root cause.
Research shows Cytonics’ novel biologic treatment can slow the degradation of cartilage from OA and even reverse the damage. Now they’re getting ready for phase 1 human clinical trials, a key step toward FDA approval. That gives them the potential to disrupt the $240b OA market.
With possibility like this, it’s no wonder Johnson & Johnson® is a significant shareholder. Join them and invest in Cytonics before their funding round closes on March 30.
|
|
Allbirds
In the wake of a disappointing end to its first 18 months as a publicly traded company, the maker of San Francisco’s favorite footwear, Allbirds, is launching a new product. And it’s got a tagline the company is hoping will resonate with shoppers, who it says are young and environmentally conscious: “The world’s first net zero carbon shoe.”
While carbon reduction is undeniably a powerful vision for fashion, it’s a claim that has commonly included carbon-credit purchases and the G-word (greenwashing). But Allbirds said its reimagining business as usual in the apparel industry, and has achieved a zero-carbon footprint with its new shoe, the “M0.0NSHOT.”
According to Allbirds, M0.0NSHOT was achieved without carbon offsets and instead uses carbon-negative materials, including those Allbirds invented itself. So while packaging and shipping the shoe will emit carbon, the product’s net carbon output balances to zero.
It’s a move that CEO Tim Brown said was made possible by the company’s relatively small size and the flexibility of its supply chain, and that Allbirds hopes will put it at the forefront of a fundamental change in footwear design and production.
Keep reading here.—MA
|
|
Hiring that isn’t tiring. Remotebase helps clients hire the top 1% of remote developers in just 24 hours. Candidates are pre-evaluated using a Silicon Valley standardized vetting process to ensure they’re a perfect match. It’s borderless hiring that offers access to a versatile talent pool, saving you time and $$$. Start your free 2-week trial.
|
|
Ethan Miller/Getty Images
Stat: $25 million. That’s the amount that Theranos founder Elizabeth Holmes allegedly owes to company creditors, according to a lawsuit recently made public and reported by NBC News.
Quote: “NOT acceptable.”—A Las Vegas city engineer’s response to Elon Musk’s The Boring Company’s proposal to expand the company’s Loop tunnel-based transportation system in the city, which would, in certain segments, limit the height of new development, prompting this response, TechCrunch reported
Read: The LA Times editorial board wrote that new fossil-fuel projects are a form of climate denial.
Test more: In-house QA can take years to scale. QA Wolf takes weeks. QA Wolf will build, run, and maintain your automated end-to-end test suite—and get you to 80% test coverage in 4 months. Learn more.*
Cybersecurity curiosity: Wanna stay up to date on the landscape of corporate security solutions? Join us as we sit down with Vanta to address the biggest questions affecting this ever-changing industry. Save your seat.*
*This is sponsored advertising content.
|
|
-
Amazon is expected to lay off another 9,000 employees, following prior layoffs.
-
Honda Civic models released in 2022 and 2023 are being reviewed by the National Highway Traffic Safety Administration following driver complaints of steering problems.
-
Meta is being sued by content moderators in Kenya.
-
Apple may soon release its latest iOS, per The Verge.
|
|
Catch up on the top Tech Brew stories from the past few editions:
|
|
✢ A Note From Cytonics
This is a paid advertisement for Cytonics’ Regulation CF Offering. Please read the offering circular at invest.cytonics.com.
|
|
Written by
Hayden Field and Maeve Allsup
Was this email forwarded to you? Sign up
here.
Guide →
What is AI?
Guide →
What is 5G?
{if !contains(profile.lists,"Marketing Brew") || !contains(profile.lists,"CFO Brew") || !contains(profile.lists,"HR Brew") || !contains(profile.lists,"EmTech Brew") || !contains(profile.lists,"IT Brew") || !contains(profile.lists,"Retail Brew") || !contains(profile.lists,"Healthcare Brew")}
Take The Brew to work
{/if}
{if !contains(profile.lists,"Marketing Brew")}
-
Marketers:
{if !contains(profile.lists,"Marketing Brew")}
Marketing Brew
{/if}
{/if}
{if !contains(profile.lists,"CFO Brew") || !contains(profile.lists,"HR Brew")}
-
Corporate:
{if !contains(profile.lists,"CFO Brew")}
CFO Brew
{/if}
{if !contains(profile.lists,"HR Brew")}
HR Brew
{/if}
{/if}
{if !contains(profile.lists,"EmTech Brew") || !contains(profile.lists,"IT Brew")}
-
Tech:
{if !contains(profile.lists,"IT Brew")}
IT Brew
{/if}
{/if}
{if !contains(profile.lists,"Retail Brew")}
-
Retailers:
Retail Brew
{/if}
{if !contains(profile.lists,"Healthcare Brew")}
-
Healthcare:
Healthcare Brew
{/if}
{if !contains(profile.lists,"Daily Business") || !contains(profile.lists,"Money Scoop") || !contains(profile.lists,"Money With Katie")}
Get smarter in just 5 minutes
{/if}
{if !contains(profile.lists,"Daily Business")}
-
Business News:
Morning Brew
{/if}
{if !contains(profile.lists,"Money Scoop") || !contains(profile.lists,"Money With Katie") || !contains(profile.lists,"Raise")}
-
Money & Career:
{if !contains(profile.lists,"Money Scoop")}
Money Scoop
{/if}
{if !contains(profile.lists,"Money With Katie")}
Money With Katie
{/if}
{if !contains(profile.lists,"Raise")}
Raise
{/if}
{/if}
Business education without the BS
Interested in podcasts?
|
ADVERTISE
//
CAREERS
//
SHOP
//
FAQ
Update your email preferences or unsubscribe
here.
View our privacy policy
here.
Copyright ©
2023
Morning Brew. All rights reserved.
22 W 19th St, 4th Floor, New York, NY 10011
|
|